Abstract
Infectivity is a fundamental property of viral pathogens such as human rhinoviruses (HRVs). This chapter describes two methods for measuring the infectivity of HRV-A and -B serotypes: end point dilution (TCID50) assay and plaque assay. End point dilution assay is a quantal, not quantitative, assay that determines the dilution of the sample at which 50 % of the aliquots have infectious virus. It can be used for all the HRV-A and -B serotypes and related clinical isolates that grow in cell culture and induce cytopathic effect (CPE), degenerative changes in cells that are visible under a microscope. Plaque assay is a quantitative assay that determines the number of infectious units of a virus in a sample. After an infectious unit of virus infects one cell, the infected cell produces progeny viruses that then infect and kill a circle of adjacent cells. This circle of dead cells detaches from the dish and thus leaves a clear hole in a cell monolayer. Plaque assay works only for HeLa-adapted HRV-A and -B serotypes that can make visible plaques on the cell monolayer. Currently the end point dilution assay and plaque assay have not been developed for the newly discovered HRV-C.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Busse WW, Lemanske RF Jr, Gern JE (2010) Role of viral respiratory infections in asthma and asthma exacerbations. Lancet 376:826–834
Ruuskanen O, Waris M, Ramilo O (2013) New aspects on human rhinovirus infections. Pediatr Infect Dis J 32:553–555
Lee WM, Lemanske RF Jr, Evans MD, Vang F, Pappas T, Gangnon R, Jackson DJ, Gern JE (2012) Human rhinovirus species and season of infection determine illness severity. Am J Respir Crit Care Med 186:886–891
Winther B (2011) Rhinovirus infections in the upper airway. Proc Am Thorac Soc 8:79–89
Turner RB, Lee WM (2009) Rhinovirus. In: Richman DD, Whitley RJ, Hayden FG (eds) Clinical virology. ASM, Washington, DC, pp 1063–1082
Turner RB, Couch RB (2007) Rhinoviruses. In: Knipe DM, Howley PM (eds) Fields virology. Lippincott Williams and Wilkins, Philadelphia, PA, pp 895–909
Horsnell C, Gama RE, Hughes PJ, Stanway G (1995) Molecular relationships between 21 human rhinovirus serotypes. J Gen Virol 76(Pt 10):2549–2555
Rueckert R (1996) Picornaviridae: the viruses and their replication. In: Fields BN, Knipe DM, Howley PM et al (eds) Fields virology, 3rd edn. Lippincott-Raven Publishers, Philadelphia, PA, pp 609–654
Savolainen C, Blomqvist S, Mulders MN, Hovi T (2002) Genetic clustering of all 102 human rhinovirus prototype strains: serotype 87 is close to human enterovirus 70. J Gen Virol 83:333–340
Ledford RM, Patel NR, Demenczuk TM, Watanyar A, Herbertz T, Collett MS, Pevear DC (2004) VP1 sequencing of all human rhinovirus serotypes: insights into genus phylogeny and susceptibility to antiviral capsid-binding compounds. J Virol 78:3663–3674
Kistler AL, Webster DR, Rouskin S, Magrini V, Credle JJ, Schnurr DP, Boushey HA, Mardis ER, Li H, DeRisi JL (2007) Genome-wide diversity and selective pressure in the human rhinovirus. Virol J 4:40
Tapparel C, Junier T, Gerlach D, Cordey S, Van Belle S, Perrin L, Zdobnov EM, Kaiser L (2007) New complete genome sequences of human rhinoviruses shed light on their phylogeny and genomic features. BMC Genomics 8:224
Palmenberg AC, Spiro D, Kuzmickas R, Wang S, Djikeng A, Rathe JA, Fraser-Liggett CM, Liggett SB (2009) Sequencing and analyses of all known human rhinovirus genomes reveal structure and evolution. Science 324:55–59
Price WH (1956) The isolation of a new virus associated with respiratory clinical disease in humans. Proc Natl Acad Sci USA 42:892–896
Pelon W, Mogabgab WJ, Phillips IA, Pierce WE (1957) A cytopathogenic agent isolated from naval recruits with mild respiratory illnesses. Proc Soc Exp Biol Med 94:262–267
Hamparian VV, Colonno RJ, Cooney MK, Dick EC, Gwaltney JM Jr, Hughes JH, Jordan WS Jr, Kapikian AZ, Mogabgab WJ, Monto A et al (1987) A collaborative report: rhinoviruses–extension of the numbering system from 89 to 100. Virology 159:191–192
Kistler A, Avila PC, Rouskin S, Wang D, Ward T, Yagi S, Schnurr D, Ganem D, Derisi JL, Boushey HA (2007) Pan-viral screening of respiratory tract infections in adults with and without asthma reveals unexpected human coronavirus and human rhinovirus diversity. J Infect Dis 196:817–825
Lau SK, Yip CC, Tsoi HW, Lee RA, So LY, Lau YL, Chan KH, Woo PC, Yuen KY (2007) Clinical features and complete genome characterization of a distinct human rhinovirus (HRV) genetic cluster, probably representing a previously undetected HRV species, HRV-C, associated with acute respiratory illness in children. J Clin Microbiol 45:3655–3664
Lee WM, Kiesner C, Pappas T, Lee I, Grindle K, Jartti T, Jakiela B, Lemanske RF Jr, Shult PA, Gern JE (2007) A diverse group of previously unrecognized human rhinoviruses are common causes of respiratory illnesses in infants. PLoS One 2:e966
McErlean P, Shackelton LA, Lambert SB, Nissen MD, Sloots TP, Mackay IM (2007) Characterisation of a newly identified human rhinovirus, HRV-QPM, discovered in infants with bronchiolitis. J Clin Virol 39:67–75
Ashraf S, Brockman-Schneider R, Bochkov YA, Pasic TR, Gern JE (2012) Biological characteristics and propagation of human rhinovirus-C in differentiated sinus epithelial cells. Virology 436:143–149
Hao W, Bernard K, Patel N, Ulbrandt N, Feng H, Svabek C, Wilson S, Stracener C, Wang K, Suzich J et al (2012) Infection and propagation of human rhinovirus C in human airway epithelial cells. J Virol 86:13524–13532
Bochkov YA, Palmenberg AC, Lee WM, Rathe JA, Amineva SP, Sun X, Pasic TR, Jarjour NN, Liggett SB, Gern JE (2011) Molecular modeling, organ culture and reverse genetics for a newly identified human rhinovirus C. Nat Med 17:627–632
Stott EJ, Tyrrell DA (1968) Some improved techniques for the study of rhinoviruses using HeLa cells. Arch Gesamte Virusforsch 23:236–244
Sherry B, Rueckert R (1985) Evidence for at least two dominant neutralization antigens on human rhinovirus 14. J Virol 53:137–143
Sherry B, Mosser AG, Colonno RJ, Rueckert RR (1986) Use of monoclonal antibodies to identify four neutralization immunogens on a common cold picornavirus, human rhinovirus 14. J Virol 57:246–257
Schmidt NJ, Emmons RW (1989) General principles of laboratory. In: Schmidt NJ, Emmons RW (eds) Diagnostic procedures for viral, rickettsial, and chlamydial infections. American Public Health Association, Washington, DC, pp 1–35
Schmidt NJ (1989) Cell culture procedures for diagnostic virology. In: Schmidt NJ, Emmons RW (eds) Diagnostic procedures for viral, rickettsial, and chlamydial infections. American Public Health Association, Washington, DC, pp 51–100
Lee WM, Monroe SS, Rueckert RR (1993) Role of maturation cleavage in infectivity of picornaviruses: activation of an infectosome. J Virol 67:2110–2122
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this protocol
Cite this protocol
Lee, WM., Chen, Y., Wang, W., Mosser, A. (2015). Infectivity Assays of Human Rhinovirus-A and -B Serotypes. In: Jans, D., Ghildyal, R. (eds) Rhinoviruses. Methods in Molecular Biology, vol 1221. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-1571-2_7
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1571-2_7
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-1570-5
Online ISBN: 978-1-4939-1571-2
eBook Packages: Springer Protocols